Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

BGIICC 2018 /
Screening for the fallopian tube as the origin of ovarian cancer

18th - 19th Jan 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 24.01.18
Views: 1043
Rating:

Prof Sean Kehoe - University of Birmingham, Birmingham, UK

Prof Kehoe speaks with ecancer at the 10th BGICC in Cairo about screening results uncovering the fallopian tubes as a primary site of tumour development.

He describes how this can mean cancer screening for ovarian or cervical cancer missing early disease, or catching what are in fact metastatic cells outside the original lesion. 

Prof Kehoe calls for greater awareness of these events, and ongoing vigilance in catching malignancies as early as possible.

Prof Kehoe also spoke with ecancer about the DESKTOPIII trial for relapsed ovarian cancer patients, here.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation